tiprankstipranks
PharmaTher Holdings Ltd (PHRRF)
OTHER OTC:PHRRF

PharmaTher Holdings Ltd (PHRRF) Stock Price & Analysis

27 Followers

PHRRF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.08 - $0.32
Previous Close$0.17
Volume41.90K
Average Volume (3M)182.16K
Market Cap
$14.53M
Enterprise Value$12.12M
Total Cash (Recent Filing)C$3.29M
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)
Beta0.94
Sep 26, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding88,169,065
10 Day Avg. Volume122,397
30 Day Avg. Volume182,165
Standard Deviation0.47
R-Squared0.05
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)4.52
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

17.58%0.00%<0.01%82.42%
17.58% Insiders
<0.01% Other Institutional Investors
82.42% Public Companies and
Individual Investors

PHRRF FAQ

What was PharmaTher Holdings Ltd’s price range in the past 12 months?
PharmaTher Holdings Ltd lowest stock price was $0.08 and its highest was $0.32 in the past 12 months.
    What is PharmaTher Holdings Ltd’s market cap?
    Currently, no data Available
    When is PharmaTher Holdings Ltd’s upcoming earnings report date?
    PharmaTher Holdings Ltd’s upcoming earnings report date is Sep 26, 2024 which is in 71 days.
      How were PharmaTher Holdings Ltd’s earnings last quarter?
      PharmaTher Holdings Ltd released its earnings results on Apr 22, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
        Is PharmaTher Holdings Ltd overvalued?
        According to Wall Street analysts PharmaTher Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does PharmaTher Holdings Ltd pay dividends?
          PharmaTher Holdings Ltd pays a Notavailable dividend of $0.02 which represents an annual dividend yield of N/A. See more information on PharmaTher Holdings Ltd dividends here
            What is PharmaTher Holdings Ltd’s EPS estimate?
            PharmaTher Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does PharmaTher Holdings Ltd have?
            PharmaTher Holdings Ltd has 88,169,070 shares outstanding.
              What happened to PharmaTher Holdings Ltd’s price movement after its last earnings report?
              PharmaTher Holdings Ltd reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 6.25%.
                Which hedge fund is a major shareholder of PharmaTher Holdings Ltd?
                Currently, no hedge funds are holding shares in PHRRF
                ---

                PharmaTher Holdings Ltd Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                16.19%
                12-Months-Change

                Fundamentals

                Return on Equity
                -90.54%
                Trailing 12-Months
                Asset Growth
                -61.38%
                Trailing 12-Months

                Company Description

                PharmaTher Holdings Ltd

                Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation, is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals. Pharmather repurposes psychedelic pharmaceuticals, such as ketamine and psilocybin, for FDA approval to treat disorders of the brain and nervous system.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                AbbVie
                Bristol-Myers Squibb
                Gilead Sciences
                Johnson & Johnson
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis